Home
About
Services
Partners
Client Portfolio
News
Contact
Fed’s Bostic: U.S. small business may need up to $500 billion monthly in support through crisis
April 16, 2020
Asian stocks set to rise as markets brace for China GDP data
April 16, 2020
0
Gilead surges after report suggests COVID-19 patients responding to remdesivir
Published by
Muller&Green
at
April 16, 2020
Categories
RSS
Tags
Shares of Gilead Sciences Inc soared 15% on Thursday after a media report suggested that severe COVID-19 patients were positively responding to the drugmaker’s experimental treatment remdesivir.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more